Required Reading – Secondary Markets, Slowing Drug Growth, Gates, Startup Mergers, etc.

by jtaylor on April 29, 2011

  • Barry Silbert discusses new secondary markets for private companies and other alternative assets (link)
  • Burrill Report – growth in drug sales slows (link)
  • Gates Foundation funding many ‘Out of the Box’ ideas (link)
  • Growing your biotech startup through mergers (link)
  • Academic biases and Biotech failures (link)

Tagged as: Academia, biotech, Burrill & Co., Drug Development, Gates Foundation, Secondary Market, Startup

Previous post:

Next post: